Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer
Clinical trial NCT03619681 · COMPLETED
Trial details
- NCT number
- NCT03619681
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-17
- Primary completion
- 2022-06-30
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.